International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Pharmacological Reviews
Sadashiva S KarnikWalter G Thomas

Abstract

The renin angiotensin system (RAS) produced hormone peptides regulate many vital body functions. Dysfunctional signaling by receptors for RAS peptides leads to pathologic states. Nearly half of humanity today would likely benefit from modern drugs targeting these receptors. The receptors for RAS peptides consist of three G-protein-coupled receptors—the angiotensin II type 1 receptor (AT1 receptor), the angiotensin II type 2 receptor (AT2 receptor), the MAS receptor—and a type II trans-membrane zinc protein—the candidate angiotensin IV receptor (AngIV binding site). The prorenin receptor is a relatively new contender for consideration, but is not included here because the role of prorenin receptor as an independent endocrine mediator is presently unclear. The full spectrum of biologic characteristics of these receptors is still evolving, but there is evidence establishing unique roles of each receptor in cardiovascular, hemodynamic, neurologic, renal, and endothelial functions, as well as in cell proliferation, survival, matrix-cell interaction, and inflammation. Therapeutic agents targeted to these receptors are either in active use in clinical intervention of major common diseases or under evaluation for repurposing in many ot...Continue Reading

References

Apr 1, 1977·Physiological Reviews·M J Peach
Feb 28, 1992·Biochemical and Biophysical Research Communications·S P BottariM de Gasparo
Jan 1, 1992·Journal of Cardiovascular Pharmacology·B BunnemannD Ganten
Oct 1, 1992·The American Journal of the Medical Sciences·D J HayzerM S Runge
Sep 30, 1992·Biochemical and Biophysical Research Communications·Y YamanoT Inagami
Jun 26, 1992·Brain Research·J W HardingJ W Wright
Jul 24, 1992·Brain Research. Developmental Brain Research·K A MartinS Hockfield
Mar 31, 1992·Biochemical and Biophysical Research Communications·S S KakarJ D Neill
May 29, 1992·Biochemical and Biophysical Research Communications·H SasamuraV J Dzau
Jan 1, 1992·Annals of Plastic Surgery·C W CruseD S Reintgen
Jan 1, 1991·The American Journal of Physiology·C Sumners, L M Myers
Jan 1, 1990·Journal of Cardiovascular Pharmacology·L CriscioneB Kamber
Jan 15, 1992·Biochemical and Biophysical Research Communications·S Chaki, T Inagami
Sep 1, 1991·Hypertension·F G Dunn, S D Pringle
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C SumnersM K Raizada
Jun 19, 1991·European Journal of Pharmacology·S P BottariM de Gasparo
Jan 1, 1991·Endocrinology·K Tsutsumi, J M Saavedra
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D YoungM Wigler
Apr 1, 1989·The Journal of Pharmacy and Pharmacology·P G Takla, C J Dakas
Nov 30, 1989·Biochemical and Biophysical Research Communications·A T ChiuA L Johnson
Aug 30, 1989·Biochemical and Biophysical Research Communications·S WhitebreadM de Gasparo
Jun 1, 1988·The American Journal of Physiology·G A VallegaR W Alexander

❮ Previous
Next ❯

Citations

Mar 19, 2016·Cellular and Molecular Neurobiology·T Michael De Silva, Frank M Faraci
Dec 16, 2016·Nature Reviews. Cardiology·Duncan J Campbell
Jun 27, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Takanobu TakezakoKoichi Node
Nov 9, 2016·Reproductive Sciences·Angela PalumboFrederick Naftolin
Apr 10, 2016·Journal of Molecular and Cellular Cardiology·Ashley L EadieKeith R Brunt
Feb 23, 2018·Antioxidants & Redox Signaling·Andreas Petry, Agnes Görlach
Aug 22, 2017·World Journal of Cardiology·Nirav Patel, Jason Gluck
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Aug 30, 2018·Physiological Reports·Diego Tomás QuirogaFernando P Dominici
Feb 6, 2017·Circulation Research·Xiaoming HuFrank M Faraci
Nov 30, 2016·Hypertension·Steven J ForresterVictor Rizzo
Nov 16, 2018·ChemMedChem·Matthias HoffmannMichael Decker
Nov 10, 2018·Expert Review of Proteomics·Ana Belén SanzAlberto Ortiz
Nov 6, 2018·Current Drug Targets·Surovi SaikiaRajeev Sarmah
May 2, 2019·Journal of the American Heart Association·Brandon A KempRobert M Carey
Mar 30, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Lucas A C SouzaYumei Feng
Jan 20, 2018·Physiological Reviews·Robson Augusto Souza SantosMaria Jose Campagnole-Santos
Oct 4, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Giovanni SansoèFlorence Wong
Apr 9, 2019·Acta Physiologica·Colin SumnersUlrike Muscha Steckelings
Dec 20, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Colin SumnersAnnette D de Kloet
Aug 21, 2019·Nature Reviews. Cardiology·Maria Paz OcaranzaSergio Lavandero
Jan 31, 2020·Circulation Research·Brandon A KempRobert M Carey
Nov 14, 2019·British Journal of Pharmacology·Y S Bakhle
Jan 31, 2020·Experimental Physiology·Priscila Ramos de OliveiraAgnaldo Bruno Chies
Oct 17, 2019·Postgraduate Medicine·Pavlina A Andreeva-GatevaIvanka I Dimova
May 19, 2020·American Journal of Physiology. Endocrinology and Metabolism·Johnny S YounisKarl Skorecki
Feb 19, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yuan-Yuan LuPing-Jin Gao
Mar 8, 2020·British Journal of Pharmacology·Y S Bakhle
Oct 28, 2019·Bone Research·Jian LuoJianru Xiao
Nov 21, 2018·Clinical and Experimental Hypertension : CHE·Yoshino MatsuoShin-Ichiro Miura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Current Opinion in Nephrology and Hypertension
Johannes Stegbauer, Thomas M Coffman
World Journal of Nephrology
Fernanda M FerrãoJennifer Lowe
Current Clinical Pharmacology
Sergio Henrique Sousa Santos, Ana Cristina Simões e Silva
© 2021 Meta ULC. All rights reserved